407 Tumor associated mitochondria antigens (TAMAs) as target for cancer vaccine: from the mechanisms to the clinical validation

• Michael Lotze,
• Andrea Facciabene,
• Stefano Pierini,
• Renzo Perales-Linares,
• Francesca Costabile,
• Costantinos Koumenis,
• Adham Bear,
• Cameron Koch,
• Linette Gerald,
• Beatriz Carreno

Affiliations

Michael Lotze

Aff1 grid.21925.3d0000000419369000Dept of ImmunologyUniv of Pittsburgh Cancer Center Pittsburgh PA USA

Andrea Facciabene

1University of Pennsylvania, Philadelphia, PA, USA

Stefano Pierini

3Carisma Therapeutics, Philadelphia, PA, USA

Renzo Perales-Linares

Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Francesca Costabile

Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Costantinos Koumenis

Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Adham Bear

1University of Pennsylvania, Philadelphia, PA, USA

Cameron Koch

1University of Pennsylvania, Philadelphia, PA, USA

Linette Gerald

1University of Pennsylvania, Philadelphia, PA, USA

Beatriz Carreno

1University of Pennsylvania, Philadelphia, PA, USA